| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,408 | 26,860 | 23,256 | 26,094 | | Cost of Revenue | 6,040 | 7,058 | 6,025 | 6,870 | | | Gross Profit | 18,368 | 19,802 | 17,231 | 19,224 | | | Operating Expenses | | Research Development | 4,425 | 5,045 | 4,970 | 5,446 | | Selling General and Administrative | 13,541 | 15,420 | 13,851 | 14,979 | | Non Recurring | 2,252 |
-
| 15,260 | 754 | | Others | 123 | 122 | 450 | 485 | | | | Total Operating Expenses | 20,341 |
-
| 34,531 | 21,664 | | | | Operating Income or Loss | (1,973) | (785) | (17,300) | (2,440) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (484) | 313 | (323) | (877) | | Earnings Before Interest And Taxes | (1,871) | (472) | (17,623) | (3,317) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,871) | (472) | (17,623) | (3,317) | | Income Tax Expense | (618) | (180) | (1,492) | 781 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,253) | (292) | (16,131) | (4,098) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,253) | (292) | (16,131) | (4,098) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,253) | ($292) | ($16,131) | ($4,098) |
|
0.51% Nasdaq 0.00%
Income Statement
